Insufficient scRNA-seq data for expression of CHRD at single-cell level.
Insufficient scRNA-seq data for expression of CHRD at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 17013.91 | 226 / 226 | 96% | 14.77 | 391 / 406 |
prostate | 99% | 2339.02 | 243 / 245 | 90% | 7.20 | 450 / 502 |
pancreas | 100% | 3063.24 | 327 / 328 | 88% | 5.79 | 156 / 178 |
brain | 84% | 5006.03 | 2226 / 2642 | 98% | 10.01 | 690 / 705 |
breast | 100% | 2665.12 | 458 / 459 | 80% | 15.14 | 889 / 1118 |
kidney | 100% | 4155.19 | 89 / 89 | 66% | 5.09 | 591 / 901 |
lung | 99% | 1669.21 | 572 / 578 | 58% | 4.43 | 675 / 1155 |
uterus | 99% | 7845.55 | 169 / 170 | 47% | 3.85 | 214 / 459 |
stomach | 97% | 1656.68 | 350 / 359 | 47% | 2.15 | 135 / 286 |
adrenal gland | 100% | 2894.37 | 258 / 258 | 30% | 1.73 | 68 / 230 |
intestine | 97% | 1549.52 | 933 / 966 | 32% | 1.78 | 170 / 527 |
bladder | 100% | 1695.24 | 21 / 21 | 28% | 1.42 | 142 / 504 |
ovary | 100% | 3892.86 | 180 / 180 | 27% | 1.17 | 115 / 430 |
esophagus | 86% | 1771.54 | 1247 / 1445 | 36% | 1.62 | 65 / 183 |
thymus | 99% | 1976.05 | 649 / 653 | 21% | 0.62 | 130 / 605 |
spleen | 100% | 2368.24 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 2649.19 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 1994.20 | 1327 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 1692.65 | 851 / 861 | 0% | 0 | 0 / 0 |
skin | 68% | 892.42 | 1225 / 1809 | 27% | 1.39 | 127 / 472 |
muscle | 74% | 591.33 | 593 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 29% | 2.79 | 13 / 45 |
lymph node | 0% | 0 | 0 / 0 | 14% | 0.49 | 4 / 29 |
eye | 0% | 0 | 0 / 0 | 3% | 0.06 | 2 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030509 | Biological process | BMP signaling pathway |
GO_0001501 | Biological process | skeletal system development |
GO_0030336 | Biological process | negative regulation of cell migration |
GO_0002053 | Biological process | positive regulation of mesenchymal cell proliferation |
GO_0045785 | Biological process | positive regulation of cell adhesion |
GO_0030514 | Biological process | negative regulation of BMP signaling pathway |
GO_0021513 | Biological process | spinal cord dorsal/ventral patterning |
GO_0045668 | Biological process | negative regulation of osteoblast differentiation |
GO_0009953 | Biological process | dorsal/ventral pattern formation |
GO_0033504 | Biological process | floor plate development |
GO_0005615 | Cellular component | extracellular space |
GO_0019955 | Molecular function | cytokine binding |
GO_0036122 | Molecular function | BMP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CHRD |
Protein name | Chordin |
Synonyms | UNQ217/PRO243 |
Description | FUNCTION: Dorsalizing factor. Key developmental protein that dorsalizes early vertebrate embryonic tissues by binding to ventralizing TGF-beta family bone morphogenetic proteins (BMPs) and sequestering them in latent complexes (By similarity). . FUNCTION: Dorsalizing factor. Key developmental protein that dorsalizes early vertebrate embryonic tissues by binding to ventralizing TGF-beta family bone morphogenetic proteins (BMPs) and sequestering them in latent complexes. . |
Accessions | ENST00000348986.3 [Q9H2X0-5] Q9H2X0 E7ESX1 ENST00000204604.6 [Q9H2X0-1] ENST00000420973.5 [Q9H2X0-4] ENST00000448472.5 [Q9H2X0-3] ENST00000450923.5 ENST00000356534.7 [Q9H2X0-2] |